Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Cambrex Acquires Leading EU Stability Storage Company Q1 Scientific 2022-06-01 18:00
PMB Announces EIT Health Supported FLASHKNiFE Consortium Towards the Clinical Application of FLASH Radiation Therapy 2022-06-01 16:15
Tau-targeting Alzheimer's treatment, HMTM, moving toward regulatory submission based on initial data from TauRx's LUCIDITY trial 2022-06-01 16:00
AMGEN AND NSG BIOLABS ANNOUNCE GOLDEN TICKET TO BOOST SINGAPORE'S BIOTECH ECOSYSTEM 2022-06-01 10:00
Antengene to Present Clinical Results of ATG-008 (Onatasertib) at the 2022 American Society of Clinical Oncology Annual Meeting 2022-06-01 08:30
Innovent Appoints Mr. Gary Zieziula as Independent Non-executive Director 2022-06-01 08:00
Kemin Food Technologies - Asia Introduces Antimicrobial Disinfectant Solutions KEEPER™ and OXINE™ 2022-06-01 08:00
CStone Pharmaceuticals Reports 2021 Annual Results and Recent Business Highlights 2022-06-01 00:35
QureBio Ltd. to Showcase its Q-1802 Clinical Advances at 2022 ASCO Annual Meetings 2022-05-31 22:30
BIOMERICS ANNOUNCES EXPANSION INTO IRELAND 2022-05-31 22:05
Nalagenetics obtains CE Mark for its pharmacogenomics software, Nala Clinical Decision Support™ Module- PGx Core 2022-05-31 21:09
Rensselaer Polytechnic Institute and Icahn School of Medicine at Mount Sinai Announce Joint Center for Engineering and Precision Medicine 2022-05-31 21:00
MGI and King Abdullah International Medical Research Center Announce Partnership for Genomic Research 2022-05-31 20:33
ETNA™ DEVICE FROM THE LEADING DIGITAL HEALTH & AI COMPANY INNODEM NEUROSCIENCES RECEIVES FDA "BREAKTHROUGH" DESIGNATION FOR MULTIPLE SCLEROSIS 2022-05-31 18:00
Medical training in Vietnam impressively attracts international students. 2022-05-30 20:08
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment 2022-05-30 16:40
Experts attending P&G Health's Global Webinar Series highlight underdiagnosis concerns as Peripheral Neuropathy becomes more prevalent 2022-05-30 16:12
RhoVac's phase IIb study in prostate cancer , BRaVac, failed to meet its primary endpoint 2022-05-30 11:04
United BioPharma Receives TFDA Approval for Phase 2 IND for UB-221 to Treat Chronic Spontaneous Urticaria 2022-05-30 10:59
Illuccix® Reimbursement Milestone and Launch Updates: Pass-Through Status Granted in the U.S. 2022-05-30 08:02
1 148 149 150 151 152 493